Dragonfly Therapeutics Announces Multi-Target Expansion of its Collaboration with Merck to Use Dragonfly's Proprietary TriNKET Platform to Develop Novel Therapeutic Candidates in the fie

Dragonfly Therapeutics is committed to discovering, developing and commercializing therapies that use its novel TriNKET? technology to harness the body's innate immune system to bring breakthrough cancer treatments to patients. For more information visit:?www.dragonflytx.com,?https://twitter.com/dragonflytxhttps://www.linkedin.com/company/dragonfly-therapeutics-inc./, or?www.facebook.com/dragonflytherapeutics/ Media Contact:??Anne Deconinck?anne@dragonflytx.com SOURCE Dragonfly Therapeutics, Inc.